Suppr超能文献

三唑仑的抗焦虑而非镇静特性可被苯二氮䓬受体拮抗剂Ro 15 - 1788逆转。

The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.

作者信息

File S E, Pellow S

出版信息

Neuropsychobiology. 1985;14(4):193-7. doi: 10.1159/000118226.

Abstract

The effects of the novel putative anxiolytic, tracazolate, were investigated in the social interaction of anxiety and the holeboard. Tracazolate (5 mg/kg) had an anxiolytic action that was no longer observed at higher doses (10-25 mg/kg); in the holeboard tracazolate produced a dose-related (5-25 mg/kg) depression of exploratory head-dipping, locomotor activity and rearing. The effects of tracazolate in the social interaction test, but not in the holeboard, could be reversed by the benzodiazepine receptor antagonist, Ro 15-1788 (10 mg/kg).

摘要

研究了新型假定抗焦虑药曲卡唑酯在焦虑的社交互动和洞板实验中的作用。曲卡唑酯(5毫克/千克)具有抗焦虑作用,而在较高剂量(10 - 25毫克/千克)时则不再观察到该作用;在洞板实验中,曲卡唑酯产生了与剂量相关(5 - 25毫克/千克)的探索性探首、运动活性和竖毛行为的抑制。苯二氮䓬受体拮抗剂Ro 15 - 1788(10毫克/千克)可逆转曲卡唑酯在社交互动实验中的作用,但不能逆转其在洞板实验中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验